LianBio - ADR

NASDAQ:LIAN   9:43:41 AM EDT
4.82
+0.10 (+2.12%)
Earnings Announcements

LianBio Provides Corporate Update And Reports Third Quarter 2021 Financial Results

Published: 12/09/2021 21:37 GMT
LianBio - ADR (LIAN) - Provides Corporate Update and Reports Third Quarter 2021 Financial Results.
Q3 Loss per Share $0.63.
Expects Current Cash and Cash Equivalents Will Be Sufficient to Fund Operating Expenses and Capital Expenditure Requirements Through 2023.
Q3 Earnings per Share View $-0.58 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.72

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.26

More details on our Analysts Page.